MedPath

Effect of baru almond in coronary heart disease risk factors

Not Applicable
Conditions
Hypercholesterolemia, Oxidative stress
C18.452.584.500.500.396
G03.495.710
Registration Number
RBR-4zdy9p
Lead Sponsor
Faculdade de Nutrição - FANUT/UFG
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Men and women alduts (19 - 60 years old); omnivores; BMI between 18.5 and 30 kilogram per meter squared; total cholesterol between 50-95 th percentile (NCEP - National Cholesterol Education Program): between 200 and 255 mg/dL for men and between 201 and 265 mg/dL for women,

Exclusion Criteria

Use of any nutritional intervention and/or drugs, such omega 3 or dietary fiber; vegetarians; presence of chronic diseases, such hypertension, diabetes, cardiovascular disease or cancer; chronic alcoholics (consumption more than 2 times a week); frequent consumption of nuts (more than 2 times a week); allergy of nuts.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
10% of reduction in serum LDL-c, after 6 weeks of supplementation with baru almond.;Serum LDL-c reduced 9.4% after 6 weeks of supplementation with baru almond.
Secondary Outcome Measures
NameTimeMethod
Reduction of cholesterol total, triglycerides and homocysteine concentrations. Increase of plasma total antioxidant capacity and improve of oxidative status. Maintenance of the body composition and dietary intake.<br>;There was a significant reduction of 8.1% in total cholesterol and non-significant 10.4% for triglycerides. The homocysteine??, total antioxidant capacity, oxidative status, body composition and dietary intake did not changed during the study.
© Copyright 2025. All Rights Reserved by MedPath